Phase 2CompletedAge-related condition
Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs (Neu I)
Phase II Study of Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs.
- Sponsor
- Neurim Pharmaceuticals Ltd. (Industry)
- Enrollment
- 40 enrolled
- Conditions
- Primary Insomnia
- Interventions
- placebo Circadin; Circadin
- Ages
- adults, older adults
- Registry
- NCT00816673
Full record on ClinicalTrials.gov
From the registry
The aim of this placebo controlled study is to investigate the effect of 2 mg melatonin Slow Release (Circadin®) on the sleep/wake cycle in elderly insomniac out-subjects, aged 55 years or more.
History
Last registry update
Registered
Study completion
Primary completion
Started